Navigation Links
BSI Introduces Entropy® Software for Healthcare Product Manufacturers
Date:6/14/2011

RESTON, Va., June 14, 2011 /PRNewswire/ -- BSI Group America Inc. (BSI), a leading global provider of ISO-standards-based assurance, compliance, and information solutions, is pleased to introduce Entropy Software for the healthcare industry. Entropy Software is a market-leading quality management software solution to assist organizations to deliver products to market on-time with transparency, real-time reporting, and improved quality and compliance assurance. Designed and developed to meet recognized international standards, Entropy Software provides a technology framework that allows companies to effectively manage for ISO 13485 and U.S. FDA compliance.

(Logo: http://photos.prnewswire.com/prnh/20110405/NE77664LOGO)

The web-based interface easily allows medical device manufacturers and pharmaceutical companies to remain compliant to complex regulatory requirements, improve business performance, and manage risk more effectively through a single-sourced solution. The user-friendly, customizable dashboards enhance and improve overall tracking of processes for internal and external requirements including ISO 9001, ISO 13485, 21 CFR Part 820, and 21 CFR Part 11.

In addition to streamlining operations, improving internal communications, and protecting brand reputation, Entropy Software can reduce costs related to legislation and regulatory requirements, products and services, quality control, non-conformance reporting, action planning, document control, and management review. It provides organizations with the features for an effective quality management system, as well as supporting conformance to ISO standards like 14001 for Environmental and OHSAS 18001 for Health and Safety.

"BSI is continually evolving and providing one-stop solutions to help clients get their products to market faster, while reducing overall costs and increasing internal efficiency," said Paul Brooks, VP Healthcare Solutions with BSI. "BSI Entropy Software helps healt
'/>"/>

SOURCE BSI Group America Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. Dr. Dello Russo Introduces the New EYE-Q Lasik
3. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
4. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
5. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
6. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
7. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
8. Siemens Introduces New Standard of Care for Breast Ultrasound
9. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
10. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
11. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Pa. , Aug. 28, 2014  Robotic ... patients, and media, both for the promise of ... safety. The quick deployment of surgical robots and ... are prompting facilities to evaluate their robotic surgery ... entire surgical team.    ECRI Institute ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... new market research report is available ... Therapeutics to 2020 - Broadened Diagnostic ... Drive Market Growth despite Patent Expirations ... ADHD Therapeutics to 2020 ...
(Date:8/28/2014)... OAKS, Calif. , Aug. 28, 2014 ... submission of a Biologics License Application (BLA) to the ... approval for the treatment of high cholesterol. Evolocumab is ... convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces ... or "bad" cholesterol, from the blood. 1 ...
Breaking Medicine Technology:Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 2Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 3Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 4Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 6Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 7Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9
... Hands Foundation announced today the donation of $75,000 to ... in the United States and Latin America. The money was ... Blue Test, supported by Roche Diabetes Care. The ... World Diabetes Day on Nov. 14. The campaign reinforces the ...
... Generex Biotechnology Corporation (OTCBB: GNBT.OB) ( www.generex.com ) ... ( www.antigenexpress.com ), will present new Phase 2 clinical ... HER-2/neu Peptide Vaccine (AE37) in HER-2 expressing breast cancer ... Cancer Symposium (SABCS) in San Antonio, Texas on December ...
Cached Medicine Technology:Big Blue Test 2011 Provides Life-Saving Insulin and Supplies to More Than 8,000 People in Need 2Big Blue Test 2011 Provides Life-Saving Insulin and Supplies to More Than 8,000 People in Need 3Big Blue Test 2011 Provides Life-Saving Insulin and Supplies to More Than 8,000 People in Need 4Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 2Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 3Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 4Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 5
(Date:8/29/2014)... First Choice Emergency Room opened ... The new facility is located 1501 FM 685, Pflugerville, Texas ... to be a part of First Choice Emergency Room’s second ... deliver high quality emergency medical care to the local community,” ... Emergency Room Pflugerville – FM 685. , To ...
(Date:8/29/2014)... What is bullying and why does it matter in ... harming, mistreatment by one or more people. It takes ... It is a form of abusive conduct very much ... bullying is a wide range of misconduct, but for us, ... short of the physical, just short of battery.” , “There ...
(Date:8/29/2014)... San Diego, CA (PRWEB) August 29, 2014 ... regarding all the latest information from the FDA on ... on August 26, that several sterile convenience surgical packs, by ... of sterility. , The reason for the recall is ... lead to loss of product sterility and infection. The affected ...
(Date:8/29/2014)... The Florida Chiropractic Association held its ... last week August 21-24 and Maryland and Virginia chiropractor ... , Dr. Greenstein presented at three different ... a standing room session; (2) A Panelist at the ... Leading the Way in Injury Prevention and Maximizing Human ...
(Date:8/29/2014)... Canadian Healthy Vending , the largest ... annual survey of its 200 operators from every region ... that appeal to Canadian consumer seeking refreshment at healthy ... top five selling healthy snacks and top five selling ... issue for consumers, employers, and families. Everyone wants to ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Pflugerville, Texas 2Health News:Bullying Expert Dr. Gary Namie discusses NCAA and Professional Sports with Sports Conflict Institute 2Health News:Bullying Expert Dr. Gary Namie discusses NCAA and Professional Sports with Sports Conflict Institute 3Health News:Sterile Convenience Surgical Packs by Customed, Inc. Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Sport and Spine Rehab’s CEO Presents at the Florida Chiropractic Association National Convention and Expo 2014 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 3
... percent of food products specifically targeted to babies and ... than 20 per centof calories coming from sugar, according ... Charlene Elliott. The study, funded by the ... sugar and sodium levels in 186 food products specifically ...
... the Gulf of Mexico, and they are concerned about its potential ... from a continuing survey conducted by the University of Minnesota. ... conducted by The Food Industry Center at the U of M. ... were aware of the spill and 85 percent say they are ...
... ... needs of athletes by offering all natural custom energy bars at elementendurance.com. , ... Chicago, IL (PRWEB) June 28, 2010 -- ... athletes to build their own all-natural, custom energy bars to their training and race needs. ...
... tooth-bleaching agent may improve the oral health of elderly ... of Georgia and Western University of Health Sciences. ... be difficult or impossible for patients with mental challenges ... medications cause xerostomia, or dry mouth, the lack of ...
... the Iacocca Foundation announce today the completion of the Phase ... as the submission of all safety reports to the U.S. ... monitoring boards. Plans for the Phase II clinical study, which ... a treatment for people with existing type 1 diabetes, are ...
... June 28, 2010 In the first ever published estimate ... with their minor children, a team led by a Wake ... cancer survivors are parenting young children, highlighting a group of ... in Cancer , a peer-reviewed journal of the American ...
Cached Medicine News:Health News:Toddler foods too sweet 2Health News:Toddler foods too sweet 3Health News:Element Endurance – Custom Energy Bars for Athletes 2Health News:Tray bleaching may improve oral health of elderly, special-needs patients 2Health News:Mass. General Hospital, Iacocca Foundation announce completion of Phase I diabetes trial 2Health News:More than a million parents with minor children are cancer survivors 2
Jaws with fine teeth. Serrated handle with polished finish. Jaws: Wide, 4.5 mm. With thumb catch lock....
Straight shafts with curved 1 x 2 teeth. Serrated handle with polished finish....
Straight shafts, 1 x 2 teeth. Wide serrated handle with polished finish. Teeth: 0.3 mm. Most popular size or model....
Straight shafts with delicate 0.7 mm, 1 x 2 teeth. Serrated handle with polished finish....
Medicine Products: